Table 1:
Distribution of variables in patients with and without BKV viremia and viruria
| Total (N = 529) | BKV viruria ≥ 10^7 (n = 89) | No viruria (n = 440) | Viremia (n = 56) | No viremia (n = 473) | |
|---|---|---|---|---|---|
| Recipient age | 38.7±10.5 | 39.4±10.9 | 38.6±10.5 | 39.7±11.8 | 38.6±10.4 |
| Males | 424 (80.1%) | 71 (79.8%) | 353 (80.2%) | 41 (73.2%) | 378 (79.9%) |
| Donor age | 48.2±9.6 | 49.9 ± 10.1 | 47.9±9.5 | 51.8 ± 9.2 | 47.8 ± 9.6 |
| Diabetes | 191 (36.1%) | 30 (33.7%) | 161 (36.6%) | 6 (10.7%) | 65 (13.7%) |
| ABOi Tx/Desensitization | 108 (20.4%) | 19 (21.3%) | 89 (20.2%) | 15 (26.8%) | 93 (19.7%) |
| BPAR | 93 (17.6%) | 20 (22.5%) | 73 (16.6%) | 16 (28.6%) | 77 (16.2%) |
| Induction | 81 (15.3%) | 14 (15.7%) | 67 (15.2%) | 11 (19.6%) | 70 (14.8%) |
| CMV | 31 (4.9%) | 4 (4.5%) | 27 (6.1%) | 4 (7.1%) | 52 (10.9%) |
| Tacrolimus metabolizer | |||||
| Extensive | 39 (7.4%) | 5 (5.6%) | 34 (7.7%) | 4 (7.1%) | 35 (7.3%) |
| Intermediate | 147 (27.7%) | 23 (25.8%) | 124 (28.2%) | 14 (25%) | 133 (28.1%) |
| Poor | 181 (34.2%) | 33 (37.1%) | 148 (33.6%) | 23 (41.1%) | 158 (33.4%) |
| Age Tac Co levels over first 2 months | 7.9 | 8 | 7.9 | 8.05 | 7.88 |
| GFR 6 m | 68±19.4 | 64.7±19 | 68.7±19.5 | 63±18.2 | 68.6±19.5 |
| GFR 12 m | 66.9±21.2 | 63.8±21 | 67.6±21.2 | 61.6±21.3 | 67.6±21 |
| Hospitalization or infection | 236 (44.6%) | 47 (52.8%) | 189 (42.9%) | 32 (57.1%) | 230 (48.6%) |
BPAR: Biopsy-proven acute rejection, ABOi Tx: ABO incompatible transplant, CMV: Cytomegalovirus, GFR: Glomerular filtration rate.